Arrakis Therapeutics’ Collaboration Agreement with Amgen

Martina Bellini
Tagged:

Goodwin Procter advised Arrakis Therapeutics on the deal.Arrakis Therapeutics announced its research collaboration agreement with Amgen (NASDAQ:AMGN), focused on the discovery and development of RNA degrader therapeutics…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now